Details of the Drug

General Information of Drug (ID: DMDXKA9)

Drug Name
CD40LGVAX
Indication
Disease Entry ICD 11 Status REF
Non-small-cell lung cancer 2C25.Y Phase 2 [1]
Cross-matching ID
TTD ID
D0V7DQ

References

1 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)